Furthermore, NK cells expanded via the engagement of the SLAMF2/CD48-SLAMF4/CD244 axis showed stronger anti-tumor capability and infiltration ability into the tumor microenvironment, leading to an improvement in therapeutic efficiency [48]. Here, CD48 is linked to neoplasm.